Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats

Midi A., EKİCİ H., KUMANDAŞ A., Durmus O., Bodic B., Tiryaki M., ...Daha Fazla

MARMARA MEDICAL JOURNAL, cilt.32, sa.1, ss.27-32, 2019 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5472/marumj.518821
  • Dergi Adı: MARMARA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.27-32
  • Anahtar Kelimeler: Algan hemostatic agent, Hemostasis, Rat, Bleeding control, Splenectomy, MEDICINAL-PLANT EXTRACT, ANKAFERD BLOOD STOPPER, N-ACETYL GLUCOSAMINE, FIBRIN SEALANT, POSTOPERATIVE ADHESIONS, ACHIEVING HEMOSTASIS, SPLENIC INJURY, SWINE MODEL, EFFICACY, MANAGEMENT
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objective: Algan hemostatic agent (AHA) is a plant-based hemostatic agent produced in Turkey. Although, there is a great improvement in the hemostatic technologies, more effective hemostatic products are required to be produced. The aim of this study was to demonstrate the efficacy of AHA in a partial splenectomy model in rats. In addition, in this model, postoperative abdominal adhesion was evaluated.